Interaction of Convulsive Ligands with Benzodiazepine Receptors
- 11 June 1982
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 216 (4551) , 1241-1243
- https://doi.org/10.1126/science.6281892
Abstract
The gamma-aminobutyric acid (GABA)-benzodiazepine receptor complex, which is composed of distinct proteins embedded in the neuronal plasma membrane, is important for several effects of benzodiazepines, including protection afforded against convulsions. During structural modification of ethyl beta-carboline-3-carboxylate an agent was discovered which has high affinity for brain benzodiazepine receptors but which is a potent convulsant. Also in contrast to benzodiazepines, this type of benzodiazepine receptor ligand favors benzodiazepine receptors in the non-GABA-stimulated conformation, which may explain the convulsive properties.This publication has 28 references indexed in Scilit:
- Antagonism of benzodiazepine receptors by beta carbolinesLife Sciences, 1981
- GABA‐Benzodiazepine‐Barbiturate Receptor InteractionsJournal of Neurochemistry, 1981
- Binding of β-Carboline-3-Carboxylic acid ethyl ester to mouse brain benzodiazepine receptors in vivoEuropean Journal of Pharmacology, 1981
- Norharman inhibition of [3H]-diazepam binding in mouse brainLife Sciences, 1981
- Ethyl β-carboline carboxylate lowers seizure threshold and antagonizes flurazepam-induced sedation in ratsNature, 1981
- The inhibition of GABA-stimulated benzodiazepine binding by a convulsant benzodiazepineLife Sciences, 1980
- Multiple benzodiazepine receptorsTrends in Neurosciences, 1980
- GABAergic modulation of benzodiazepine binding site sensitivityNature, 1978
- Properties of 3H-diazepam binding to benzodiazepine receptors in rat cerebral cortexLife Sciences, 1977
- Benzodiazepine receptors in rat brainNature, 1977